NGR4 and ERBB4 as Promising Diagnostic and Therapeutic Targets for Metabolic Disorders

NGR4 and ERBB4 as Promising Diagnostic and Therapeutic Targets for Metabolic Disorders

Obese individuals are at high risk for developing type 2 diabetes mellitus, cardiovascular diseases, and nonalcoholic fatty liver disease. The aim of this review was to analyze the scientific literature and databases to reveal the fundamental role of neuregulin 4 (NRG4) and its receptors in the deve...

Full description

Bibliographic Details
Main Authors: Maria Vulf, Maria Bograya, Alexandra Komar, Olga Khaziakhmatova, Vladimir Malashchenko, Kristina Yurova, Anastasiya Sirotkina, Anastasiya Minchenko, Elena Kirienkova, Natalia Gazatova, Larisa Litvinova
Format: Article
Language:English
Published: IMR Press 2023-06-01
Series:Frontiers in Bioscience-Elite
Subjects:
erbb signaling
nrg4
erbb4
obesity
type 2 dm
nafld
mirna
snp
Online Access:https://www.imrpress.com/journal/FBE/15/2/10.31083/j.fbe1502014

Internet

https://www.imrpress.com/journal/FBE/15/2/10.31083/j.fbe1502014

Similar Items